Koers Cardiome Pharma Corp. Nasdaq
Aandelen
CA14159U2020
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
2020 | Transcript : Correvio Pharma Corp. - Shareholder/Analyst Call | |
2019 | Transcript : Correvio Pharma Corp., Q3 2019 Earnings Call, Nov 14, 2019 |
Omzet 2018 | 28,67 mln. 26,82 mln. | Omzet 2019 | 32,63 mln. 30,52 mln. | Marktkapitalisatie | 27,28 mln. 25,52 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -16 mln. -14,96 mln. | Nettowinst (verlies) 2019 | -35 mln. -32,73 mln. | EV/omzet 2018 | 5,13 x |
Nettoschuld 2018 | 25,92 mln. 24,24 mln. | Nettoschuld 2019 | 33,9 mln. 31,71 mln. | EV/omzet 2019 | 1,87 x |
K/w-verhouding 2018 |
-7,1
x | K/w-verhouding 2019 |
-0,68
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 86,23% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,31% | 70,44 mld. | |
+10,97% | 8,94 mld. | |
-16,83% | 4,75 mld. | |
+43,48% | 4,5 mld. | |
+3,20% | 3,85 mld. | |
+18,82% | 2,38 mld. | |
-21,36% | 2,34 mld. | |
-29,67% | 2,2 mld. | |
+8,38% | 1,96 mld. |
- Beurs
- Aandelen
- Koers CORV
- Koers